Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 6 open reading frame 141 (C6orf141) is a small, uncharacterized human protein encoded on chromosome 6p12.3[1][4]. Its expression is broadly detected in normal tissues and is reduced in various cancer types, most notably in oral squamous cell carcinoma, where its low protein levels are associated with advanced tumor stage, nodal involvement, and poor prognosis[2][4]. Functional studies indicate that C6orf141 suppresses tumor proliferation, migration, and invasion in vitro and in vivo[4]. Its biological role may be context-dependent and is the subject of ongoing research in cancer biology, with explorations into its potential as a tumor suppressor and cancer biomarker[2][4]. No role as a canonical drug target, receptor, or enzyme is currently established[1][2][4][5].
None established for drugs (not a known drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 141 (C6orf141).